GlassScriptPhysician profile
Nalini B Mehta
NPI 1487607750
$9,126.55
in general payments reported to CMS, 2019-2025
54 companies · $775 in 2025
The $775 reported for 2025 was more than what 79% of Therapeutic Radiology providers received nationally (typical 2025 total: $179).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,441 · 2020: $1,159 · 2021: $581 · 2022: $1,009 · 2023: $2,288 · 2024: $873 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,749 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,749.14 |
| Education | $186.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,456.78 | 2019-2024 | Opdivo, Pomalyst, Opdualag |
| Janssen Biotech, INC. | $1,169.35 | 2019-2025 | Erleada, Tecvayli, Rybrevant |
| Seagen INC. | $670.93 | 2019-2023 | Adcetris |
| Jazz Pharmaceuticals INC. | $533.21 | 2021-2023 | |
| Genentech USA, INC. | $470.56 | 2019-2025 | Tecentriq, Polivy |
| Bayer Healthcare Pharmaceuticals INC. | $454.24 | 2019-2023 | |
| Astellas Pharma US INC | $321.60 | 2019-2024 | Padcev |
| Astrazeneca Pharmaceuticals LP | $290.21 | 2019-2025 | Lynparza, Imfinzi |
| Incyte Corporation | $244.37 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Exelixis INC. | $232.77 | 2020-2025 | Cabometyx |
| Merck Sharp & Dohme LLC | $214.67 | 2021-2025 | Keytruda, Welireg |
| Eisai INC. | $177.92 | 2019 | |
| Pfizer INC. | $157.81 | 2024 | |
| Daiichi Sankyo INC. | $155.74 | 2024-2025 | Enhertu, Vanflyta |
| Reflexion Medical, INC. | $147.61 | 2023-2025 | Reflexion Medical Radiotherapy System |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nalini Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.